SLN

Silence TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

SLN vs peer average

44/100

SLN vs. peer average (D vs. D)

Grade spread

A 1 · C 4 · D 3 · F 3

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

LRMR is the first available peer comparator.

Clinical-stage small-cap biotech with a concentrated lead-asset thesis and sharp repricing around binary development milestones; useful as a risk-profile peer more than a mechanistic peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerLRMRLarimar Therapeutics

SLN

Silence Therapeutics

LRMR

Larimar Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs LRMR

SLN / LRMR

Grade Position

Below peers

SLN vs. peer average (D vs. D)

44/100

Momentum

SLN

Value

SLN

Sentiment

LRMR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs SLN

LRMR

60/100

-1

TARA

40/100

Even

FHTX

100/100

-3

AQST

Aquestive Therapeutics Inc Common

20/100

ASMB

Assembly Biosciences Inc Common

20/100

LRMR is the first peer returned for this comparison set.